cyproterone acetate has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrison, M; Markus, H; Polkey, M | 1 |
1 other study(ies) available for cyproterone acetate and Day Blindness
| Article | Year |
|---|---|
Visual loss and optic atrophy associated with cyproterone acetate.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Humans; Male; Optic Atrophy; Vision Disorders | 1992 |